A framework for clinical and translational research in the era of rigor and reproducibility

被引:15
作者
Wichman, Chris [1 ]
Smith, Lynette M. [1 ]
Yu, Fang [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA
关键词
Rigor; reproducibility; team science; clinical translational research; replicability; CELL LUNG-CANCER; OPEN-LABEL; CRIZOTINIB; CHEMOTHERAPY; SCIENCE; TRIAL; GENE;
D O I
10.1017/cts.2020.523
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Rigor and reproducibility are two important cornerstones of medical and scientific advancement. Clinical and translational research (CTR) contains four phases (T1-T4), involving the translation of basic research to humans, then to clinical settings, practice, and the population, with the ultimate goal of improving public health. Here we provide a framework for rigorous and reproducible CTR. Methods: In this paper we define CTR, provide general and phase-specific recommendations for improving quality and reproducibility of CTR with emphases on study design, data collection and management, analyses and reporting. We present and discuss aspects of rigor and reproducibility following published examples of CTR from the literature, including one example that shows the development path of different treatments that address anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC). Results: It is particularly important to consider robust and unbiased experimental design and methodology for analysis and interpretation for clinical translation studies to ensure reproducibility before taking the next translational step. There are both commonality and differences along the clinical translation research phases in terms of research focuses and considerations regarding study design, implementation, and data analysis approaches. Conclusions: Sound scientific practices, starting with rigorous study design, transparency, and team efforts can greatly enhance CTR. Investigators from multidisciplinary teams should work along the spectrum of CTR phases, and identify optimal practices for study design, data collection, data analysis, and results reporting to allow timely advances in the relevant field of research.
引用
收藏
页数:10
相关论文
共 52 条
[1]  
[Anonymous], 2002, J NEGATIVE RESULTS B
[2]  
Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a
[3]  
Bennett LM, 2012, J INVEST MED, V60, P768, DOI 10.2310/JIM.0b013e318250871d
[4]   Replication [J].
Blainey, Paul ;
Krzywinski, Martin ;
Altman, Naomi .
NATURE METHODS, 2014, 11 (09) :879-880
[5]   Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCW .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :40-44
[6]   Quality evidence for policymaking: I'll believe it when I see the replication [J].
Brown, Annette N. ;
Cameron, Drew B. ;
Wood, Benjamin D. K. .
JOURNAL OF DEVELOPMENT EFFECTIVENESS, 2014, 6 (03) :215-235
[7]   Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer [J].
Camidge, D. R. ;
Kim, H. R. ;
Ahn, M. -J. ;
Yang, J. C. -H. ;
Han, J. -Y. ;
Lee, J. -S. ;
Hochmair, M. J. ;
Li, J. Y. -C. ;
Chang, G. -C. ;
Lee, K. H. ;
Gridelli, C. ;
Delmonte, A. ;
Garcia Campelo, R. ;
Kim, D. -W. ;
Bearz, A. ;
Griesinger, F. ;
Morabito, A. ;
Felip, E. ;
Califano, R. ;
Ghosh, S. ;
Spira, A. ;
Gettinger, S. N. ;
Tiseo, M. ;
Gupta, N. ;
Haney, J. ;
Kerstein, D. ;
Popat, S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) :2027-2039
[8]   NIH plans to enhance reproducibility [J].
Collins, Francis S. ;
Tabak, Lawrence A. .
NATURE, 2014, 505 (7485) :612-613
[9]  
Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.1038/bjc.2014.639, 10.7326/M14-0697, 10.1002/bjs.9736, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1111/eci.12376, 10.1136/bmj.g7594, 10.7326/M14-0698, 10.1016/j.eururo.2014.11.025]
[10]   MAXIMUM LIKELIHOOD FROM INCOMPLETE DATA VIA EM ALGORITHM [J].
DEMPSTER, AP ;
LAIRD, NM ;
RUBIN, DB .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1977, 39 (01) :1-38